ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±Ò¶Ð¡Ý¼¡¢ ¡¢¡¢ÁÖΰ½Ü£©°¢¶û´Äº£Ä¬²¡£¡£¨AD£©ÊÇÍíÄê³Õ´ô×î³£¼ûÐÎʽ£¬£¬£¬ÆäÌصãÊÇÈÏÖª¹¦Ð§µÄ¾ÙÐÐÐԺͲ»¿ÉÄæתÐÔµÄË¥ÍË¡£¡£¾Ýͳ¼Æ£¬£¬£¬È«Çòƽ¾ùÿ3Ãë¾ÍÐÂÔöÒ»ÃûAD»¼Õߣ¬£¬£¬ÎÒ¹úAD»¼ÕßÊýÄ¿¸ß´ï980Íò¡£¡£Ëæ×ÅÎÒ¹úÉú³ÝÀÏÁ仯Ç÷ÊƼӾ磬£¬£¬¿ª·¢ÓÐÓ÷½°¸Ô¤·ÀºÍÖÎÁÆAD±äµÃÓÈΪ½ôÆÈ¡£¡£
½üÄêµÄÑо¿ÌáÐÑ£¬£¬£¬ÄÔѪ¹Ü¹¦Ð§ÕÏ°ÊÇAD²¡ÀíÀú³ÌÖеÄÒ»¸öÖ÷ÒªÔçÆÚÊÂÎñ¡£¡£Ñª¹ÜÄÚƤÉú³¤Òò×ÓA£¨VEGFA£©ÔÚµ÷ÀíѪ¹ÜµÄ¶àÖÖÐÄÀí¹¦Ð§ºÍ²¡Àíת±äÖÐÊ©Õ¹×ÅÒªº¦×÷Ó㬣¬£¬µ«VEGFAÊÇ·ñ¼ÓÈëADÔçÆÚ²¡ÀíÏ£ÍûÉв»ÇåÎú¡£¡£¿ËÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺҶСݼÍŶӡ¢ ¡¢¡¢ËïÒÝÏɼÍÄîÒ½ÔºÁÖΰ½ÜÍŶӺÍÌÆÑÇ÷ÍŶÓÁªºÏÔÚTranslational NeurodegenerationÆÚ¿¯½ÒÏþÌâΪ¡°Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer¡¯s disease¡±µÄÑо¿ÂÛÎÄ¡£¡£
¸ÃÂÛÎı¨µÀÁËÔÚÁÙ´²°©Ö¢ÖÎÁÆÖÐÓÃÓÚ¿¹Ñª¹ÜÌìÉúµÄµ¥¿Ë¡¿¹VEGFA¿¹Ìå±´·¥µ¥¿¹£¬£¬£¬¿ÉÏÔÖø¸ÄÉÆÔçÆÚADÄ£×ÓСÊóµÄ³¤Ê±³ÌÓ°Ï󣬣¬£¬ïÔ̺£ÂíÄÔÇøºÍƤ²ãµí·ÛÑù°ß¿é³Á»ý£¬£¬£¬²¢ÒÖÖƽºÖÊϸ°ûµÄ»î»¯¡£¡£Ñо¿Ö°Ô±½øÒ»²½·¢Ã÷£¬£¬£¬ÔÚÔçÆÚADÄ£×ÓСÊóÖУ¬£¬£¬VEGFAÊÜÌåÂѰ׵ıí´ïˮƽ¾ßÓÐÐÔ±ð²î±ðÐÔת±ä£¬£¬£¬¶ø±´·¥µ¥¿¹¿ÉÒÔͨ¹ýÐÔ±ð²î±ðÐÔµ÷ÀíVEGFAÊÜÌåµÄ±í´ïˮƽ£¬£¬£¬Éϵ÷ÓëÄÔѪ¹Ü¹¦Ð§Ïà¹ØµÄ»ùÒò±í´ïºÍÐźÅͨ·£¬£¬£¬¸ÄÉÆѪÄÔÆÁÕÏ£¬£¬£¬ÔöÇ¿ÄÔѪ¹Ü·´Ó³ÐÔ£¬£¬£¬²¢ïÔÌÖÐÐÔÁ£Ï¸°ûÔÚÄÔëϸѪ¹ÜÖеÄÖÍÁô¡£¡£ÕâЩЧ¹ûÌáÐÑ£¬£¬£¬¡°ÀÏÒ©ÐÂÓᱵı´·¥µ¥¿¹ÔÚ¼õ»ºÔçÆÚADÀú³ÌÖоßÓнÏÇ¿µÄDZÁ¦£¬£¬£¬Ö¸³öÐÞ¸´ÄÔѪ¹Ü¹¦Ð§¿É×÷Ϊ¸ÉÔ¤ADÈÏÖªËðÉ˵ÄÖ÷Òª°ÐµãºÍÐÂÕ½ÂÔ¡£¡£
Ñо¿Ê¾Òâͼ
ÖÐɽҽѧԺ2023Äê½áÒµµÄ²©Ê¿Ñо¿ÉúÕÅÃô¡¢ ¡¢¡¢ËïÒÝÏɼÍÄîÒ½Ôº2021¼¶²©Ê¿Ñо¿ÉúÕÅչΪÂÛÎĵÄÅäºÏµÚÒ»×÷Õß¡£¡£ÁÖΰ½Ü½ÌÊÚ¡¢ ¡¢¡¢Ò¶Ð¡Ý¼½ÌÊÚºÍÌÆÑÇ÷½ÌÊÚΪÂÛÎĵÄÅäºÏͨѶ×÷Õß¡£¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://doi.org/10.1186/s40035-023-00388-4
µØµã:¹ãÖÝÊÐиÛÎ÷·135ºÅ Óʱà:510275
µç»°: 020-84112828
ngµç×ÓÓÎÏ·°æȨËùÓÐ COPYRIGHT?1999-2022 , SUN YAT-SEN UNIVERSITY